The Eijkman Molecular Biology Research Center, formerly Eijkman Institute for Molecular Biology is a laboratory in Jakarta, Indonesia. It is most known for the discovery by Christiaan Eijkman that Beriberi was caused by a lack of thiamine in the human body.

During the past decade, Eijkman Institute for Molecular Biology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eijkman Institute for Molecular Biology" #1 collaborator was "Eijkman Institute for Molecular Biology" with 1 trials as a collaborator and "Indonesia-MoH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Eijkman Institute for Molecular Biology" are "Glucose-6-Phosphate Dehydrogenase Deficiency" (1 trials) and "Malaria" (1 trials). Many other conditions were trialed in "Eijkman Institute for Molecular Biology" in a lesser frequency.

Most popular intervention types in "Eijkman Institute for Molecular Biology" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active ingredient" (1 trials), "Spatial Repellent product with active ingredient (SHIELD)" (1 trials) and "Spatial Repellent product without active ingredient (SHIELD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eijkman Institute for Molecular Biology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Eijkman Institute for Molecular Biology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Eijkman Institute for Molecular Biology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eijkman Institute for Molecular Biology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".